These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. From the smallest virus to the biggest gene: marching towards gene therapy for duchenne muscular dystrophy. Duan D Discov Med; 2006 Jun; 6(33):103-8. PubMed ID: 17234143 [TBL] [Abstract][Full Text] [Related]
5. Myodys, a full-length dystrophin plasmid vector for Duchenne and Becker muscular dystrophy gene therapy. Duan D Curr Opin Mol Ther; 2008 Feb; 10(1):86-94. PubMed ID: 18228186 [TBL] [Abstract][Full Text] [Related]
6. The role of immunosuppression in gene- and cell-based treatments for duchenne muscular dystrophy. Arruda VR Mol Ther; 2007 Jun; 15(6):1040-1. PubMed ID: 17510638 [No Abstract] [Full Text] [Related]
8. New developments in the use of gene therapy to treat Duchenne muscular dystrophy. Jarmin S; Kymalainen H; Popplewell L; Dickson G Expert Opin Biol Ther; 2014 Feb; 14(2):209-30. PubMed ID: 24308293 [TBL] [Abstract][Full Text] [Related]
9. Design of trans-splicing adeno-associated viral vectors for Duchenne muscular dystrophy gene therapy. Lai Y; Li D; Yue Y; Duan D Methods Mol Biol; 2008; 433():259-75. PubMed ID: 18679629 [TBL] [Abstract][Full Text] [Related]
10. Cautious welcome for gene editing of Duchenne muscular dystrophy in animal model. Hawkes N BMJ; 2016 Jan; 351():h7033. PubMed ID: 26729900 [No Abstract] [Full Text] [Related]
11. A New Kid on the Playground of CRISPR DMD Therapy. Duan D Hum Gene Ther Clin Dev; 2017 Jun; 28(2):62-64. PubMed ID: 28609189 [No Abstract] [Full Text] [Related]
12. Cardiac Myoediting Attenuates Cardiac Abnormalities in Human and Mouse Models of Duchenne Muscular Dystrophy. Atmanli A; Chai AC; Cui M; Wang Z; Nishiyama T; Bassel-Duby R; Olson EN Circ Res; 2021 Sep; 129(6):602-616. PubMed ID: 34372664 [TBL] [Abstract][Full Text] [Related]